These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 15167592

  • 1. A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: ten-year follow-up.
    el-Agroudy AE, Sobh MA, Hamdy AF, Ghoneim MA.
    Transplantation; 2004 May 15; 77(9):1371-6. PubMed ID: 15167592
    [Abstract] [Full Text] [Related]

  • 2. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: long-term follow-up and study of metabolic consequences.
    Sobh MA, Hamdy AF, El Agroudy AE, El Sayed K, El-Diasty T, Bakr MA, Ghoneim MA.
    Am J Kidney Dis; 2001 Mar 15; 37(3):510-7. PubMed ID: 11228175
    [Abstract] [Full Text] [Related]

  • 3. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome.
    Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL.
    Transplantation; 1994 Mar 27; 57(6):889-92. PubMed ID: 8154037
    [Abstract] [Full Text] [Related]

  • 4. Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study.
    Sobh M, el-Agroudy A, Moustafa F, Harras F, el-Bedewy M, Ghoneim M.
    Am J Nephrol; 1995 Mar 27; 15(6):493-9. PubMed ID: 8546171
    [Abstract] [Full Text] [Related]

  • 5. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 6. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L, Ding T, Wang XX, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681
    [Abstract] [Full Text] [Related]

  • 8. Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study.
    el-Dahshan KF, Bakr MA, Donia AF, Badr Ael-S, Sobh MA.
    Nephrol Dial Transplant; 2004 Jun 31; 19(6):1613-7. PubMed ID: 15034161
    [Abstract] [Full Text] [Related]

  • 9. Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study.
    El-Dahshan KF, Bakr MA, Donia AF, Badr Ael-S, Sobh MA.
    Am J Nephrol; 2006 Jun 31; 26(3):293-8. PubMed ID: 16804292
    [Abstract] [Full Text] [Related]

  • 10. A single-centre, open-label, prospective study of an initially short-term intensified dosing regimen of enteric-coated mycophenolate sodium with reduced cyclosporine A exposure in Chinese live-donor kidney transplant recipients.
    Cai L, Zeng F, Liu B, Wei L, Chen Z, Jiang J.
    Int J Clin Pract Suppl; 2014 Apr 31; (181):23-30. PubMed ID: 24673716
    [Abstract] [Full Text] [Related]

  • 11. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 12. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.
    Transpl Int; 2016 Jan 27; 29(1):23-33. PubMed ID: 26729582
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 14. Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.
    Liu LS, Li J, Chen XT, Zhang HX, Fu Q, Wang HY, Xiong YY, Liu S, Liu XM, Li JL, Huang M, Wang CX.
    Int J Clin Pract Suppl; 2015 May 27; (183):43-52. PubMed ID: 26177348
    [Abstract] [Full Text] [Related]

  • 15. Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis.
    el-Husseini A, el-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmad N, Sobh M.
    Pediatr Nephrol; 2004 Sep 27; 19(9):976-81. PubMed ID: 15241676
    [Abstract] [Full Text] [Related]

  • 16. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Clin Exp Nephrol; 2007 Jun 27; 11(2):151-155. PubMed ID: 17593515
    [Abstract] [Full Text] [Related]

  • 17. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.
    Eisen HJ, Hobbs RE, Davis SF, Laufer G, Mancini DM, Renlund DG, Valantine H, Ventura H, Vachiery JL, Bourge RC, Canver CC, Carrier M, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Master R, Michaud JL, Paradis I, Smith A, Vanhaecke J, Mueller EA.
    Transplantation; 1999 Sep 15; 68(5):663-71. PubMed ID: 10507486
    [Abstract] [Full Text] [Related]

  • 18. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 15; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 19. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
    Baboolal K.
    Transplantation; 2003 Apr 27; 75(8):1404-8. PubMed ID: 12717239
    [Abstract] [Full Text] [Related]

  • 20. Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis.
    El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmed N, Sobh M.
    Am J Nephrol; 2004 Apr 27; 24(3):301-6. PubMed ID: 15133323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.